With the growing prevalence of type 2 diabetes and obesity worldwide, new medications continue to reshape treatment approaches. Two prominent injectable medications that have gained attention are Mounjaro (tirzepatide) and Trulicity (dulaglutide). Both belong to the GLP-1 receptor agonist family,...